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It is well established that Parkinson’s disease leads to impaired learning from reward and
enhanced learning from punishment. The administration of dopaminergic medications reverses this
learning pattern. However, few studies have investigated the neural underpinnings of these
cognitive processes. In this study, using fMRI, we tested a group of Parkinson’s disease patients on
and off dopaminergic medications and matched healthy subjects. All subjects completed an fMRI
cognitive task that dissociates feedback learning from reward versus punishment. The
administration of dopaminergic medications attenuated BOLD responses to punishment in the
bilateral putamen, in bilateral dorsolateral prefrontal cortex and the left premotor cortex. Further,
the administration of dopaminergic medications resulted in a higher ratio of BOLD activity
between reward and punishment trials in these brain areas. BOLD activity in these brain areas was
significantly correlated with learning from punishment, but not from reward trials. Furthermore,
the administration of dopaminergic medications altered BOLD activity in the right insula and
ventromedial prefrontal cortex when Parkinson’s disease patients were anticipating feedback.
These findings are in agreement with a large body of literature indicating that Parkinson’s disease
is associated with enhanced learning from punishment. However, it was surprising that
dopaminergic medications modulated punishment learning as opposed to reward learning,
although reward learning has been directly linked to dopaminergic function. We argue that these
results might be attributed to both a change in the balance between direct and indirect pathway
activation in the basal ganglia as well as the differential activity of D1 versus D2 dopamine
receptors.
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Converging evidence suggests that Parkinson’s disease impairs sensitivity to rewards and
enhances learning based on punishment feedback, while antiparkinsonian dopaminergic
agents reverse this learning pattern (Bodi et al., 2009; Frank et al., 2004). This is thought to
stem from the imbalance between direct and indirect basal ganglia pathways in Parkinson’s
disease, which is reversed by dopaminergic medications. Various studies have suggested a
functional segregation between the direct and indirect pathways in the striatum, implicating
the direct pathway in reward processing and the indirect pathway in punishment learning
(Frank et al., 2004; Bromberg-Martin et al., 2010; Lobo et al., 2010; Hikida et al., 2010;
Ferguson et al., 2011; Kravitz et al., 2012). The direct and indirect pathways reflect a dual
organization of the coritco-striato-thalamo-cortico loops, with distinct connectivity patterns
and physiological properties of the striatum and basal ganglia. Dopamine stimulates the
direct pathway through D1 receptors which initiates a (“Go”) signal, while it inhibits
indirect pathways via D2 receptors which results in a (“NoGo”) signal. Therefore, the lack
of dopamine, as in Parkinson’s disease, may increase indirect pathway activity relative to
direct pathway processing, leading to the observed imbalance in punishment based and
reward based learning. Conversely, too much dopamine might cause an overly activated
direct pathway resulting in higher sensitivity to reward as compared to punishment (Hikida
et al., 2010).

Author Manuscript

To date, the neural underpinnings of the effects of Parkinson’s disease versus those of
dopaminergic medications on learning have not been sufficiently studied using
neuroimaging. Electrophysiological studies suggest that dopamine neuronal firing increases
in response to unexpected reward and dips after the omission of reward (Bromberg-Martin et
al., 2010; Schultz et al., 1997). Further, dopaminergic neurons code for motivational salience
during both reward and punishment (Barr et al., 2009; Bromberg-Martin et al., 2010; Fadok
et al., 2009). Previous studies in healthy volunteers have reported striatal activation during
learning from both reward and punishment feedback (Garrison et al., 2013). However, it was
unclear how striatal activity during reward and punishment feedback is related to
dopaminergic modulation.

Author Manuscript

In this study, we aimed to investigate the relationship between neural activation during
learning from reward and punishment in Parkinson’s disease patients before and during
treatment with dopaminergic medications. We utilized a computer-based cognitive task,
developed by Gluck and colleagues at Rutgers University-Newark, and similar to that used
by Bodi et al. (2009), to dissociate learning from reward and punishment. Our main
hypothesis was that the dopamine-depleted striatum in medication-withdrawn Parkinson’s
disease patients will have increased activation in response to punishment than to reward,
while the administration of dopaminergic medication would reverse this relationship: neural
responses would be higher with reward than punishment.
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Methods
Participants

Author Manuscript

We tested 11 patients with Parkinson’s disease (4 female, age: 63.1 ± 10.3, age range:
45-75) and 11 healthy volunteers (age: 57.6 ± 8.5, age range: 43-72; no significant age
difference between groups: t=1.37, df=20, p=0.19). All Parkinson’s disease patients were
tested under two conditions; a dopamine OFF and ON condition, in a within-subject design.
Of the 11 Parkinson’s disease patients, six were on levodopa only, while the other five
patients were on a combination of levodopa and dopamine agonist (pramipexole). The
average dosage of levodopa and pramipexole were 542 ± 172 mg and 2.8 mg ± 0.7
respectively (altogether Levodopa Equivalent Dose: 822 ± 242 mg). As expected, treated
patients (ON) had better UPDRS scores. For the OFF state, participating Parkinson’s disease
patients were withdrawn from their medications (levodopa or pramipexole or both
respectively) for a minimum of 18 hours before testing. Patients experienced severe
worsening in their symptoms on OFF days reflected in their UPDRS (OFF UPDRS: 18.6
± 7.2; ON UPDRS: 10.8 ± 6.1, paired-samples t-test p<0.001). The average disease duration
was 5.5 ± 2.8 years, and average H&Y was 1.9 ± 0.6.
All participants gave written informed consent that was previously approved by the IRB of
Feinstein Institute for Medical Research, Manhasset, NY. Participants were recruited from
the Long Island Jewish Health System, NY.
Experimental task

Author Manuscript

We used a computer-based cognitive task that dissociates learning from reward and
punishment. The task which was developed by Gluck and colleagues at Rutgers University –
Newark was previously used in fMRI (Mattfeld et al., 2011) and cognitive studies of
Parkinson’s disease patients (Bodi et al., 2009). We modified the cover story to simulate real
life experiences. Further, we increased the duration of stimulus presentation. In each trial,
participants were presented with a casino roulette wheel (with a different background image)
and were instructed that these roulette wheels were either biased to the red or the black side
of the screen as shown in Figure 1. When the roulette wheel appeared on the screen, subjects
were asked to put their tokens on red or black by pressing MRI compatible buttons with their
thumb or index finger, respectively. Subjects were told that based on where the roulette ball
landed, they would win money, lose money or get an empty box. The task did not include
any further details about the biases of the four different roulette wheels. Therefore, subjects
were required to learn the associations by trial-and-error. Each participant started the
experiment with 500 tokens. Subjects were instructed to earn as many tokens as possible.

Author Manuscript

Each trial began with the presentation of one of four roulette wheels with their respective
background images and a casino table with instructions to place bets. The roulette wheel
(cue) was presented for a fixed period of 3 seconds and was followed by a fixation cross for
8-10 seconds. Feedback was then presented for 3 seconds followed by a fixation cross for
10-12 seconds. Thus, an average trial was 26 seconds long. Feedback was either a reward
with a smiley face indicating winning 25 tokens, a punishment with a sad face indicating
losing 25 tokens, or an empty box indicating a neutral outcome (no feedback).
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Two of the roulette wheels were biased toward red, and the other two were biased toward
black. Two roulette wheels (one red-biased and one black-biased) were pre-assigned to
result in reward if answered optimally and no feedback if answered non-optimally, while the
other two give punishment if answered non-optimally and no feedback if answered
optimally. In reward trials, when participants selected an optimal choice, they received
reward feedback with 80% probability. They received no feedback for the remaining 20% of
the trials when they selected the optimal choice. However, if the participant selected a
nonoptimal choice, they would receive reward feedback with 20% probability, but no
feedback for the remaining 80% of the trials. Similarly, on the punishment trials, when
participants selected the optimal choice, they received no feedback 80% of trials and
punishment in the remaining 20% of trials and vice versa.

Author Manuscript

All participants completed four scanning runs per session except one Parkinson’s disease
subject who had only two runs in the OFF condition. The order of stimulus presentation was
randomly determined. A run consisted of 20 trials, with each run lasting 8 minutes and 40
seconds. We calculated optimal responses and reaction time in each run for both reward and
punishment. We also measured learning scores, which was the difference between the
average of the optimal responses in the 3rd and 4th runs from the average optimal responses
in the 1st run. Using the same approach, we also calculated reaction time for reward and
punishment trials.
MRI acquisition

Author Manuscript

MRI scans were conducted at the North Shore University Hospital on a single 3T scanner
(GE Signa HDx; General Electric, Milwaukee, Wisconsin). For image registration, we
acquired anatomical scans in the coronal plane using an inversion-recovery prepared 3D fast
spoiled gradient (IR-FSPGR) sequence (TR = 7.5 ms, TE = 3 ms, TI = 650 ms matrix =
256×256, FOV = 240 mm) producing 216 contiguous images (slice thickness = 1mm)
through the whole brain. All scans were reviewed by a radiologist and a member of the
research team. Any scan with significant artifacts was repeated. We also acquired functional
scans comprising of 264 echo-planner imaging (EPI) volumes per run with the following
parameters: TR = 2000 ms, TE = 30 ms, matrix = 64*64, FOV = 240 mm, slice thickness =
3 mm, 40 continuous axial oblique slices (one voxel = 3.75×3.75×3 mm). During data
acquisition, the behavioral task was presented on an MR compatible screen.
Image processing and statistical analysis

Author Manuscript

We used FSL (http://www.fmrib.ox.ac.uk) FEAT for preprocessing and for the statistical
analysis of our images. First level analysis consisted of standard preprocessing, modeling
and the calculation of the transformation matrix of the registration. Standard preprocessing
and modeling included removal of the first four “dummy” scans, motion correction and
spatial smoothing (6-mm FWHM Gaussian kernel) followed by GLM estimation of
parameters associated with the design matrix variables. We modeled the hemodynamic
response functions (HRFs) in two different ways. First, we modeled the HRF associated
with the feedback types (reward, punishment, and no feedback). Second, we analyzed our
data in the anticipation phase, modeling our HRF locked to the different type of cues
(reward or punishment). In both type of analysis (feedback or anticipation) a custom boxcar
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function associated with the 3s presentation of feedback and cue was convoluted with
standard HRF. In addition to these variables, we added to the GLM the first time derivative
of these variables and the six movement parameters to regress out large effects of movement.
Further, standard registration and normalization to MNI152 space were also carried out, and
registration matrices were calculated for the second level analysis. During the first level
analysis, we also contrasted punishment versus reward in both feedback and anticipation.
This was followed by a group level analysis – multi-way ANOVA, with factors of feedback
type (reward or punishment), medication condition (ON, OFF), repetitions (four runs). Posthoc calculations were carried out with Featquery and lab-based R scripts. All the reported
results were cluster corrected for the whole brain with p<0.05 (with standard FSL z=2.3
initial threshold). No mask was used at any point during the analysis.

Results
Author Manuscript

Behavioral results

Author Manuscript

Parkinson’s disease patients were unable to learn to categorize the roulette wheels correctly.
Learning curves did not increase significantly in any of the treatment conditions (F1,164=0.3,
p=0.56) with the average correct response of 61.5 ± 25.3% and 51.8 ± 23.9% across trial
types for OFF and ON conditions respectively. Learning score did not show differences
between reward and punishment trials in any of the treatment conditions (condition:
F1,38=1.68, p=0.2; trial type: F1,38=1.76, p=0.19, interaction: F1,38=0.13, p=0.72). However,
Parkinson’s disease patients’ reaction time suggested that they learned whether a roulette
wheel represents a reward or a punishment cue. Patients responded to reward cues
progressively faster during the course of the runs, in both ON and OFF condition (average
reaction time changes: reward-OFF and ON: −370 ms and −302 ms, punishment OFF and
ON: 53 ms and 54 ms respectively, repeated ANOVA, condition: F1,38=0.06, p=0.81; trial
type: F1,38=6.3, p=0.02, interaction: F1,38=0.05, p=0.82; Figure 2). This significant
difference indicates that Parkinson’s disease patients differentiated trials based on their
associated feedback. The lack of difference in reaction times in general (1914 ± 487 ms and
1911 ± 466 ms OFF and ON respectively) between treatment conditions suggests that our
behavioral and neuroimaging results are not merely the result of Parkinson’s disease motor
symptoms and dopaminergic medications.

Author Manuscript

Age-matched healthy volunteers showed very similar results: 61.5 ± 25.4% correct response
across both trial types. Healthy controls showed moderate improvement in learning scores
only in punishment, but not reward, trials across runs (8.1 % (t=1.56, df=10, p=0.15) and
12.3 % (t=2.46, df=10, p=0.03) in reward and punishment trials respectively). Reaction
times were similar to those of the Parkinson’s disease cohort (RT=1515 ± 359 ms) and
became progressively faster for reward trials as compared to punishment trials (reward: −204
ms, punishment: +1 ms; F1,19=6.19, p=0.02, Figure S1, Supplementary Digital Content).
Feedback related BOLD activations
Feedback, in general, strongly activated the dorsal attention network, the salience network
and the occipital areas across trial types (Figure S2, regions listed in Table S1, cluster
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corrected p<0.05, Supplementary Digital Content). There was no deactivation at this same
level of significance of the main effect.
When we compared the effect of medication status without differentiating trial types, no
effect was detected. While BOLD activity was not modulated by medication status in reward
trials, we found that medication status significantly attenuated response to punishment trials
(OFF>ON) in several brain regions (L and R DLPFC, L and R putamen and L premotor
cortex; cluster corrected p<0.05, Table 1). When we explicitly tested whole brain voxel level
interaction between feedback type (reward versus punishment) and medication status (OFF
versus ON) the same brain regions remained significantly engaged (Figure 3A, cluster
corrected p<0.05).

Author Manuscript

Post hoc analysis of these regions revealed the same pattern across all the regions (condition:
F1,792=11.5, p<0.001, feedback: F1,792=1.1, p=0.3, region: F1,792=1.9, p=0.17, feedbackcondition interaction: F1,792 = 39.0, p<0.001): significantly higher BOLD signal during
punishment trials than in the reward trials in the OFF condition. Activation during
punishment trials significantly decreased in ON condition (Figure 3B). Side by side
comparison of the activations of the healthy controls and Parkinson’s disease patients in
different treatment conditions indicated that activation patterns in healthy controls looked
similar to OFF conditions in all regions (Figure S3, Supplementary Digital Content, Figure
3B).

Author Manuscript

By correlating BOLD responses with behavioral results, we found that the average
difference in activation between punishment and reward trials correlated with learning
scores. This was true for all five regions that were activated (L and R DLPFC, L and R
putamen and L premotor cortex). The higher the BOLD activity in these brain regions during
punishment trials in reference to reward trials the better the individual learned to categorize
punishment cues. Post-hoc analyses showed that activity in these brain regions showed no
connection to learning to categorize reward cues (General Linear Model: punishment-reward
BOLD signal: F1,60= 15.8, p<0.001, feedback type: F1,60=9.6, p=0.003; medication:
F1,60=3.3, p=0.08, and region: F4,60=0.16, p=0.96.(Figure 4, only first two areas showed
here, for all the values see Table S2).
Anticipation: cue-related BOLD activity

Author Manuscript

The main effect of anticipation (Figure S4, regions listed in Table S1, Supplementary Digital
Content) involved similar areas as the main effect of feedback (Figure S2, Supplementary
Digital Content). The dorsal attention network, the salience network, and the occipital areas
were similarly activated across trial types and medication conditions after the presentation of
cues. BOLD activity in the anticipation phase was more robust than it was after feedback, as
it is apparent from comparing Figure S2 and S4 (Supplementary Digital Content) on the
same scale. Anticipation, unlike feedback, elicited significant “negative activation” in the
vmPFC (Area 11m and 14r, Mackey and Petrides, 2014) and the parieto-temporal juncture
(Figure S4, Supplementary Digital Content). While the interpretation of the negative peaks
is often problematic, these regions likely represent true deactivations given the spatial
overlap with the default mode network. Voxel wised paired t-test between OFF and ON
condition revealed that vmPFC/gyrus rectus had significantly lower BOLD activity during
Neuroreport. Author manuscript; available in PMC 2019 May 02.
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the ON condition in both cue types (Figure 5A, Table 1). Moreover, the right anterior insula
was significantly activated in the ON condition (Figures 5A and 5B, Table 1). There was no
interaction between medication condition and cue types. Anticipatory activity did not
correlate with the behavioral findings. In the right insula, the BOLD activation during OFF
condition showed closer resemblance with healthy controls (Figure S5, Supplementary
Digital Content. Figure 5B). This was similar what we reported above regarding the brain
regions activated by feedback. However, the pattern in the vmPFC/gyrus rectus was similar
between healthy subjects and ON condition (Figure S5, Supplementary Digital Content,
Figure 5B).

Discussion

Author Manuscript

This study demonstrated that the administration of dopaminergic medications to Parkinson’s
disease patients was associated with modulation of the neural response to both feedback and
anticipation. First, dopaminergic medications attenuated the neural response to punishment
feedback in the left and right putamen, the left and right dlPFC and the left premotor cortex.
The same regions exhibited a higher ratio of activity between reward and punishment during
the ON condition as compared to the OFF condition. Neural activity correlated with the
behavioral output in punishment trials only, implicating the role of these regions in
processing punishment feedback. Second, we detected enhanced right insula activation and
attenuated vmPFC/gyrus rectus activation during the anticipation phase in the ONmedication condition. This effect was similar for both reward and punishment trials.

Author Manuscript
Author Manuscript

These data are consistent with previous behavioral studies that found opposite patterns of
sensitivity to reward and punishment between dopamine depleted (OFF) and dopamine
supplemented (ON) conditions in Parkinson’s disease (Bodi et al., 2009; Frank et al., 2004).
In agreement with these previous results, we have found higher BOLD activity in response
to punishment as compared to reward during the OFF condition. Conversely, during the ON
condition, punishment related BOLD activity was significantly decreased, while reward
related activity remained unaffected, such that the ratio of activity between reward and
punishment was higher during the ON condition as compared to the OFF condition. Our
analysis revealed that this pattern of BOLD activity was not only limited to the dorsal
striatum but was also observed in the dlPFC bilaterally and in the left premotor cortex.
These findings indicate that the observed BOLD activity reflects modulation along the
fronto-striatal circuits, not only within the striatum. The feedback-related pattern of BOLD
activity correlated strongly among the observed regions (putamen, DLPFC, and premotor
area) indicating that these regions operate within the same neural network to execute this
behavior. These observations are also congruent with the proposed model of functional
segregation between direct and indirect pathways within the basal ganglia, attributing
changes in BOLD activity during the ON vs. OFF conditions to differential engagement of
the indirect pathway (Frank et al., 2004; Bromberg-Martin et al., 2010; Lobo et al., 2010;
Hikida et al., 2010; Ferguson et al., 2011; Kravitz et al., 2012). An alternative explanation is
offered by Keeler et al. who argue that these cognitive differences can be explained by the
activation of D1 versus D2 receptors in the direct and indirect pathways, respectively, where
the direct pathway codes for habitual responses, while indirect pathway codes for goal
directed behavior (Keeler et al., 2014). This theory predicts that shortening of reaction time
Neuroreport. Author manuscript; available in PMC 2019 May 02.
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is an indicator that task is becoming more habitual, thus mediated by higher D1 receptor
activation. In our behavioral results, reaction times became shorter only during reward
related trials, during both OFF and ON conditions, indicating that both of these theories are
potentially consistent with our results. Most critically, according to both theories, our data
suggest that the administration of dopaminergic medications interfered mainly with the
indirect D2 pathway, not with the direct D1 pathway. These results are surprising since
levodopa is thought to change phasic dopamine signaling and enhance activity in the direct
D1 pathway. D2 receptors, on the other hand, are thought to be driven by tonic dopamine
levels (Moustafa et al., 2013). Prior computational modeling of phasic and tonic
characteristics of dopamine release in the dorsal striatum have suggested, however, that the
relationship between D1 and D2 receptor pathways is much more complex than initially
thought (Dreyer et al., 2010), and D2 receptor postsynaptic signaling can be significantly
activated through phasic dopamine modulation.

Author Manuscript
Author Manuscript

Inferring a dopamine-related mechanism based BOLD signals can be problematic since
BOLD responses are not a direct measure of dopamine activation. Recent evidence,
however, suggests that dopamine release can increase BOLD activity in the dorsal striatum
in a dose dependent manner (Ferenczi et al., 2016). Our healthy control data provides
additional insights into the interpretation of the BOLD signal by establishing a baseline for
acquired BOLD signal from Parkinson’s disease patients. The decaying nature of dopamine
signals during cognitive tasks can be explained by phasic dopamine prediction error
signaling in response to unexpected feedback in the first runs. This suggests that feedback
related BOLD activity during the first half of the session (run 1 and 2) might be attributed to
variations in dopaminergic signaling (Figure S4, Supplementary Digital Content). The
decrease in BOLD activity in response to reward versus punishment feedback further
strengthen the case that the measured BOLD signals are related to reward prediction error
(Schultz et al., 1997). Because of the nature of our task, reward trials elicited high reward
prediction error initially. As subjects learned that a cue was rewarding (manifested in
decreasing reaction time), reward prediction error decreased. On the other hand, irrespective
of the subject’s knowledge of the punishment related cues, it always elicited high
punishment prediction error during punishment trials indicating that processing of
punishment feedback is not a mirror image of reward feedback, but could have different
neural underpinnings (Hikida et al., 2010; Kravitz et al., 2012). However, it is important to
note that while punishment prediction error signaling can decrease dopaminergic activation,
it can manifest as higher BOLD activity due to active disinhibition of the indirect pathway.

Author Manuscript

In contrast to the feedback-related BOLD signals, the anticipation BOLD signals can be
explained by dopaminergic signaling associated with the salience of stimuli given the lack of
change in these signals over time (Figure S6, Supplementary Digital Content). Further, the
anticipatory BOLD signals were mainly observed in salience-related brain regions (Seeley et
al., 2007). It is well established that salient stimuli elicit BOLD activity in the anterior insula
as a part of the salience network, while the vmPFC tends to deactivate as a part of default
mode network. According to this model, administration of dopaminergic medications made
participants more sensitive to external stimuli. We acknowledge, however, that our task was
not designed to dissociate motivational salience and motivational value related BOLD
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activations (Bromberg-Martin et al., 2010). Hence, the BOLD signals could be driven by
both salience and value.
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In contrast to other studies by Gluck and colleagues using variations on this task, patients in
our study were unable to learn the optimal cue-outcome associations. This was likely due to
the current task design where cue and feedback were separated by 8-12 seconds, in contrast
to previous studies where feedback was directly displayed after the subject selected a choice
(Bodi et al., 2009; Mattfeld et al., 2011). The longer inter-stimuli interval was chosen to
make a clearer distinction between feedback and anticipation related BOLD signals.
However, this design made processing cue-feedback associations much more difficult. Also,
because of the increased inter-stimuli intervals, we could only deliver half as many trials as
in the previous studies. Although subjects did not learn the optimal associations, the trial
type (reward or punishment) was increasingly identified across the runs as implicated by the
decreasing reaction time after reward-only associated cues. Thus, these reaction time
changes verify that patients were learning and performing reinforcement learning.
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Another likely consequence of the current task design was that while a strong interaction
between dopaminergic medication and the neural response to punishment was evident, the
effect on reward learning was unclear. Furthermore, since the anticipation phase (part of the
current design) did not distinguish between reward and punishment related BOLD signals,
future work might benefit from examining the neural correlates of motivational bias with the
original task design (Bodi et al., 2009). Using high resolution fMRI, Mattfeld et al. (2011)
found that in healthy young participants, unique subregions of the striatum—separated along
both a dorsal/ventral and anterior/posterior axis— differentially participate in the learning of
associations through reward and punishment. This double dissociation within the striatum
can help differentiate between learning from reward versus punishment and how variability
in dopaminergic signaling individually modulates them.
Understanding the role of dopamine in reward and punishment processing could provide
valuable insight into the understanding of impulse control disorders, amotivational
syndromes, and major depressive disorder. In impulse control disorders, patients
underestimate risks and overestimate potential rewards possibly due to the imbalance in
learning from rewarding and punishing stimuli (de Ruiter et al., 2008). In sharp contrast,
depressed patients are thought to be overly sensitive to punishment as compared to reward
(Eshel and Roiser, 2010; Herzallah et al., 2013; Must et al., 2006).
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In sum, we demonstrated the modulation of the neural encoding of feedbacks across trial
types (reward or punishment) and treatment condition (OFF and ON) involving the frontostriatal circuitry (DLPFC, premotor and putamen). These results indicate that during the ON
condition there is a relative hypersensitivity toward rewards, which reverses during the OFF
condition. This flip has the potential to make patients vulnerable to cognitive distortions,
which could be the underlying neural mechanism through which dopamine depleted, and
dopamine enhanced conditions can lead to behavioral manifestations such as clinical
depression and compulsive gambling.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.

Abbreviations
BOLD

Blood oxygen level dependent

DLPFC

dorsolateral prefrontal cortex

UPDRS

Unified Parkinson’s Disease Rating Scale
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Figure 1.

Illustration of the reward and punishment learning task. First, there is the presentation of the
cue. The participant has 4 seconds to choose either red or black. Feedback is shown after
8-12 seconds (randomized) of waiting period. Similarly, feedback is followed by 8-12
seconds long period. These longer periods prevent HRFs (hemodynamic response function)
to interfere across trials and provide a framework to model anticipation and feedback
separately. (For more detail see text.)
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Figure 2.

Reaction time change. The figure illustrates that the reaction times decrease selectively in
reward cue related trials. The chart indicates that participant learned to distinguish between
the cues (reward or punishment). There was no difference across treatment conditions.
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Figure 3.

A. Neuroimaging results: interaction between trial types and treatment condition. B. Post
hoc presentation of the significant regions of the interaction analysis in Figure 3A. The first
two columns are OFF and ON conditions in Parkinson’s disease, while the last column
represents HC. Each row represents the average values of the respective regions (R-PUT and
L-PUT: right and left putamen, R-DLPFC and L-DLPFC: right and left dorso-lateral
prefrontal cortex, L-PMC: left premotor cortex) from the primary analysis. The most
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significant differences were found between OFF and ON in the punishment trials. For more
details see text.
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Figure 4.

Neuroimaging findings correlated with learning. Average activation differences during the
feedback period between punishment and reward trials predicted learning from punishment,
but not from reward. R-PUT: right putamen, L-PUT: left putamen.
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Figure 5.
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A. Neuroimaging results: the main effect of treatment condition during the anticipation of
the feedback. R-Insula had increased activation during ON condition, while left vmPFC
(ventro-medial prefrontal cortex) had lower activation during ON condition. B. Post-hoc
presentation of the significant regions of the treatment condition analysis in Figure 5A. The
first two columns are OFF and ON conditions in Parkinson’s disease, while the last column
represents HC. Each row represents the average values of the respective regions (vmPFC:
ventro-medial prefrontal cortex, R-INSULA: right insula) from the primary analysis. The
most significant differences were found between OFF and ON conditions. For more details
see text.
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Regions modulated by dopamine administration
Regions

x

y

z

peak z

Feedback modulated by dopamine
Premotor Cortex, BA 6 L

−32

−2

52

3.7

Putamen R

20

4

14

3.4

Putamen L

−22

12

4

3.4

DLPFC R

50

43

21

3.4

−43

43

22

3.2

DLPFC L

Anticipation modulated by dopamine
vmPFC, BA 11m and 14r

4

39

−18

4.8

Insula R

38

20

2

3.9
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x,y,z: MNI coordinates; peak coordinates reported z>2.3 and cluster corrected p<0.05
DLPFC: Dorso-lateral Prefrontal Cortex, vmPFC: Ventro-medial Prefrontal Cortex
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